Study of Atomoxetine in the Prevention of Vasovagal Syncope — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Atomoxetine in the Prevention of Vasovagal Syncope — Stella

Recruiting

Back to Vasovagal Syncope trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Canada

University of Calgary, Calgary, Alberta

Key details

Phase

Large-scale testing

Sponsor

University of Calgary

Enrollment target

~180 participants

Started

June 2022

Primary completion

September 2026

Age range

18 Years and older

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov